Methylphenidat Alternova

Methylphenidate, the active ingredient in Methylphenidat Alternova, is a central nervous system stimulant presented as a strength/form for oral use. It treats attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults.

GNH USA supplies Methylphenidat Alternova as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylphenidate is indicated for conditions within the central nervous system stimulant therapeutic pathway.

- Attention deficit hyperactivity disorder (children and adolescents): Improves concentration, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): Enhances focus and decreases distractibility. - Narcolepsy: Decreases excessive daytime sleepiness and improves wakefulness.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or cramps. - Nausea: feeling of sickness with possible vomiting. - Increased heart rate: tachycardia or palpitations.

Serious or Rare Side Effects: - Severe hypertension: markedly elevated blood pressure. - Psychosis: hallucinations or delusional thinking. - Cardiac arrhythmia: irregular heart rhythm. - Allergic reaction (anaphylaxis): severe swelling, rash, or breathing difficulty. - Priapism: prolonged, painful erection. - Growth suppression: reduced growth velocity in children.

Precautions should be observed before and during therapy with methylphenidate.

- Cardiovascular assessment: evaluate heart disease before initiating therapy. - Psychiatric monitoring: watch for new or worsening mental health symptoms. - Growth monitoring: assess height and weight in children regularly. - Potential for abuse: prescribe only when benefits outweigh risks and monitor use. - Pregnancy and lactation: discuss risks; classified as Category C. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Methylphenidate may interact with several drug classes; careful review is required.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects. - Antihypertensive agents: may reduce efficacy of blood pressure control.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may increase methylphenidate levels. - Alcohol: may enhance central nervous system effects. - Anticholinergic drugs: may exacerbate dry mouth and constipation.